FIELD: biotechnology.
SUBSTANCE: group of inventions is described, including a derivative of peptide nucleic acid, a pharmaceutical composition for the treatment of diseases or conditions related to the expression of a human tyrosinase gene, including effective amount of the derivative of peptide nucleic acid, a pharmaceutical composition for the treatment of hyperpigmentation related to the expression of the human tyrosinase gene, including effective amount of the derivative of peptide nucleic acid, a method for the treatment of diseases or conditions related to the expression of the human tyrosinase gene, including administration of the derivative of peptide nucleic acid, a method for the treatment of hyperpigmentation related to the expression of the human tyrosinase gene, including the administration of the derivative of peptide nucleic acid, the use of the derivative of peptide nucleic acid in the production of a drug for the treatment of diseases or conditions related to the expression of the human tyrosinase gene, and the use of the derivative of peptide nucleic acid in the production of a drug for the treatment of hyperpigmentation related to the expression of the human tyrosinase gene.
EFFECT: invention expands the arsenal of remedies complementary purposefully affecting pre-mRNA of human tyrosinase.
9 cl, 22 dwg, 3 tbl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ANTISENSE OLIGONUCLEOTIDES OF ACETYL-COA-CARBOXYLASE-2 | 2019 |
|
RU2807629C2 |
| EXON SKIP WITH PEPTIDONUCLEIC ACID DERIVATIVES | 2017 |
|
RU2786637C2 |
| ANTISENSE OLIGONUCLEOTIDES TO HIF-1-ALPHA | 2017 |
|
RU2753517C2 |
| ANTISENSE OLIGONUCLEOTIDES OF ANDROGEN RECEPTOR | 2017 |
|
RU2753966C2 |
| ANTISENSE OLIGONUCLEOTIDES FOR SNAP25 | 2017 |
|
RU2766701C2 |
| ANTISENSE OLIGONUCLEOTIDES AGAINST SCN9A | 2017 |
|
RU2748834C2 |
| ANTISENSE ANALGESIC FOR SCN9A | 2018 |
|
RU2762293C2 |
| ANTISENSE OLIGONUCLEOTIDES OF MATRIX METALLOPROTEINASE-1 | 2019 |
|
RU2802418C2 |
| PEPTIDE NUCLEIC ACID DERIVATIVES WITH GOOD CELL PENETRATION AND STRONG AFFINITY FOR NUCLEIC ACID | 2009 |
|
RU2564032C2 |
| COMPOUND FOR MODULATION OF C9ORF72 GENE EXPRESSION AND USE THEREOF | 2013 |
|
RU2730677C2 |
